Citadel Advisors - EPIRUS BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

EPIRUS BIOPHARMACEUTICALS IN's ticker is and the CUSIP is 29428P907. A total of 2 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Citadel Advisors ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$3,000
+200.0%
1,000
+900.0%
0.00%–
Q2 2015$1,000–100–0.00%–
 Download
Other shareholders
EPIRUS BIOPHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 100$00.00%
Citadel Advisors 1,000$3,0000.00%
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders